Exor: New €500 Million Buyback Takes Aim At The NAV Discount

Summary Exor’s H1 NAV declined 3.9%, but the portfolio continues to rotate away from automotive exposure, with Philips and Lingotto becoming increasingly important. The €500 million buyback should be NAV-accretive, while Exor retains significant financial flexibility for new investments and potential M&A. Portfolio simplification continues with the exits from GEDI, Lifenet, and NUO, while the agreed Welltec disposal delivers a solid 2.4x MOIC. Despite recent share-price gains, Exor continues to trade at a substantial discount to NAV, supporting our positive investment thesis and Buy rating. SOMATUSCANI/iStock Editorial via Getty Images We last commented on Exor N.V. ( EXXRF ) with an analysis called " Deep NAV Discount Persists Despite Lingotto Momentum And Portfolio Rotation " in March 2026. For our new readers, Exor is the holding company of the This article was written by Mare Evidence Lab 6.18K Followers Follow Buy-side hedge professionals conducting fundamental, income oriented, long term analysis across sectors globally in developed markets. Please shoot us a message or leave a comment to discuss ideas.DISCLOSURE: All of our articles are a matter of opinion, informed as they might be, and must be treated as such. We take no responsibility for your investments but wish you best of luck. Analyst’s Disclosure: I/we have a beneficial long position in the shares of EXXRF either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.